Search Results - "BUGHANI USHA" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

T cell activation and differentiation is modulated by a CD6 domain 1 antibody Itolizumab

T cell activation and differentiation is modulated by a CD6 domain 1 antibody Itolizumab

by Bughani, Usha, Saha, Arindam, Kuriakose, Anshu, Nair, Reshmi, Sadashivarao, Ravindra B, Venkataraman, Rasika, Patel, Swati, Deshchougule, Anuja Tushar, S, Satish Kumar, Montero, Enrique, Pai, Harish V, Palanivelu, Dinesh V, Melarkode, Ramakrishnan, Nair, Pradip
Published in PloS one (03.07.2017)

Get full text

Journal Article

Correction: T cell activation and differentiation is modulated by a CD6 domain 1 antibody Itolizumab

Correction: T cell activation and differentiation is modulated by a CD6 domain 1 antibody Itolizumab

by Bughani, Usha, Saha, Arindam, Kuriakose, Anshu, Nair, Reshmi, Sadashivarao, Ravindra B, Venkataraman, Rasika, Patel, Swati, Tushar Deshchougule, Anuja, Satish, Kumar S, Montero, Enrique, Pai, Harish V, Palanivelu, Dinesh V, Melarkode, Ramakrishnan, Nair, Pradip
Published in PloS one (30.01.2018)

Get full text

Journal Article

874 Development of BCA101, a bifunctional antibody capable of simultaneously disabling EGFR and TGFβ signaling, as novel single-agent immunotherapy

874 Development of BCA101, a bifunctional antibody capable of simultaneously disabling EGFR and TGFβ signaling, as novel single-agent immunotherapy

by Boreddy, Srinivas Reddy, Nair, Reshmi, Banerjee, Arindam, Kuriakose, Anshu, Pandey, Prashant Kumar, Dey, Chaitali, Shri, Meena, Rao, Shruthi, Shivakumar, Bhadravathi Marigowda, Kuriakose, Moni Abhram, Reddy, Ram Bhupal, Suresh, Amritha, Moole, Praveen Reddy, Bughani, Usha, Tan, Seng-Lai, Nair, Pradip
Published in Journal for immunotherapy of cancer (01.11.2021)

Get full text

Journal Article

Chemoprevention of familial adenomatous polyposis by bromo-noscapine (EM011) in the ApcMin/+ mouse model

Chemoprevention of familial adenomatous polyposis by bromo-noscapine (EM011) in the ApcMin/+ mouse model

by Li, Shiwang, Ghaleb, Amr M., He, Jing, Bughani, Usha, Bialkowska, Agnieszka B., Yang, Vincent W., Joshi, Harish C.
Published in International journal of cancer (15.09.2012)

Get full text

Journal Article

Enhanced soluble production of biologically active recombinant human p38 mitogen-activated-protein kinase (MAPK) in Escherichia coli

Enhanced soluble production of biologically active recombinant human p38 mitogen-activated-protein kinase (MAPK) in Escherichia coli

by Khattar, Sunil K, Gulati, Pankaj, Kundu, Prabuddha K, Singh, Vibhuti, Bughani, Usha, Bajpai, Malini, Saini, Kulvinder S
Published in Protein and peptide letters (01.08.2007)

Get more information

Journal Article

BCA101 Is a Tumor-Targeted Bifunctional Fusion Antibody That Simultaneously Inhibits EGFR and TGFβ Signaling to Durably Suppress Tumor Growth

BCA101 Is a Tumor-Targeted Bifunctional Fusion Antibody That Simultaneously Inhibits EGFR and TGFβ Signaling to Durably Suppress Tumor Growth

by Boreddy, Srinivas Reddy, Nair, Reshmi, Pandey, Prashant Kumar, Kuriakose, Anshu, Marigowda, Shivakumar Bhadravathi, Dey, Chaitali, Banerjee, Arindam, Kulkarni, Hanumant, Sagar, Milind, Krishn, Shiv Ram, Rao, Shruthi, Ar, Madhukara, Tiwari, Vinita, Alke, Bhavna, Mv, Prashantha Kumar, Shri, Meena, Dhamne, Chaitrali, Patel, Sonal, Sharma, Pinky, Periyasamy, Sankar, Bhatnagar, Jaya, Kuriakose, Moni Abraham, Reddy, Ram Bhupal, Suresh, Amritha, Sreenivas, Suma, Govindappa, Nagaraja, Moole, Praveen Reddy, Bughani, Usha, Tan, Seng-Lai, Nair, Pradip
Published in Cancer research (Chicago, Ill.) (02.06.2023)

Get full text

Journal Article

MK2: a novel molecular target for anti-inflammatory therapy

MK2: a novel molecular target for anti-inflammatory therapy

by Duraisamy, Senthil, Bajpai, Malini, Bughani, Usha, Dastidar, Sunanda G, Ray, Abhijit, Chopra, Puneet
Published in Expert opinion on therapeutic targets (01.08.2008)

Get more information

Journal Article

CD6 USE OF A CD6 BINDING PARTNER AND METHOD BASED THEREON

CD6 USE OF A CD6 BINDING PARTNER AND METHOD BASED THEREON

by BUGHANI USHA, NAIR PRADIP, MANIAN BALA S, BARVE ABHIJIT, MELARKODE RAMAKRISHNAN, MONTERO CASIMIRO JOSE ENRIQUE
Year of Publication 14.07.2021

Get full text

Patent

항-CD6 항체 조성물 및 COVID-19를 포함하는 코로나 바이러스의 부정적인 영향의 치료 및 감소 방법

항-CD6 항체 조성물 및 COVID-19를 포함하는 코로나 바이러스의 부정적인 영향의 치료 및 감소 방법

by BUGHANI USHA, LEON MONZON KALET, RAMAKRISHNAN MELARKODE SUBBARAMAN, NAIR PRADIP, ATHALYE SANDEEP NILKANTH, RAMOS SUZARTE MAYRA, CROMBET RAMOS TANIA, MAZUMDARSHAW KIRAN, CASIMIRO JOSE ENRIQUE MONTERO
Year of Publication 14.12.2022

Get full text

Patent

Abstract 6339: BCA101, a novel tumor-targeted bifunctional fusion antibody simultaneously inhibiting EGFR and TGF-β signaling with potential for durable tumor growth inhibition

Abstract 6339: BCA101, a novel tumor-targeted bifunctional fusion antibody simultaneously inhibiting EGFR and TGF-β signaling with potential for durable tumor growth inhibition

by Boreddy, Srinivas Reddy, Nair, Reshmi, Pandey, Prashant Kumar, Kuriakose, Anshu, Banerjee, Arindam, Dey, Chaitali, R, Madhukara A, Shivakumar, Bhadravathi Marigowda, Kulkarni, Hanumant, Sagar, Milind, V, Prashantha Kumar M., Krishn, Shiv Ram, Bhatnagar, Jaya, Kuriakose, Moni Abhram, Reddy, Ram Bhupal, Suresh, Amritha, Moole, Praveen Reddy, Bughani, Usha, Tan, Seng-Lai, Nair, Pradip, Salazar, Rachel
Published in Cancer research (Chicago, Ill.) (04.04.2023)

Get full text

Journal Article

CD6 USE OF A CD6 BINDING PARTNER AND METHOD BASED THEREON

CD6 USE OF A CD6 BINDING PARTNER AND METHOD BASED THEREON

by BUGHANI USHA, NAIR PRADIP, MANIAN BALA S, BARVE ABHIJIT, MELARKODE RAMAKRISHNAN, MONTERO CASIMIRO JOSE ENRIQUE
Year of Publication 23.10.2019

Get full text

Patent

이톨리주맙의 CD6 에 대한 인산화 감소 용도

이톨리주맙의 CD6 에 대한 인산화 감소 용도

by BUGHANI USHA, SADASHIVARAO RAVINDRA BELAVINAKODIGE, NAIR PRADIP, SAHA ARINDAM, MELARKODE RAMAKRISHNAN
Year of Publication 21.06.2019

Get full text

Patent

Chemoprevention of familial adenomatous polyposis by bromo-noscapine (EM011) in the Apc(Min/+) mouse model

Chemoprevention of familial adenomatous polyposis by bromo-noscapine (EM011) in the Apc(Min/+) mouse model

by Li, Shiwang, Ghaleb, Amr M, He, Jing, Bughani, Usha, Bialkowska, Agnieszka B, Yang, Vincent W, Joshi, Harish C
Published in International journal of cancer (15.09.2012)

Get full text

Journal Article

Chemoprevention of familial adenomatous polyposis by bromo‐noscapine (EM011) in the Apc Min/+ mouse model

Chemoprevention of familial adenomatous polyposis by bromo‐noscapine (EM011) in the Apc Min/+ mouse model

by Li, Shiwang, Ghaleb, Amr M., He, Jing, Bughani, Usha, Bialkowska, Agnieszka B., Yang, Vincent W., Joshi, Harish C.
Published in International journal of cancer (15.09.2012)

Get full text

Journal Article

Molecular targeting of E3 ligases--a therapeutic approach for cancer

Molecular targeting of E3 ligases--a therapeutic approach for cancer

by Lakshmanan, Manikandan, Bughani, Usha, Duraisamy, Senthil, Diwan, Manish, Dastidar, Sunanda, Ray, Abhijit
Published in Expert opinion on therapeutic targets (01.07.2008)

Get more information

Journal Article

Abstract 939: Chemoprevention of familial adenomatous polyposis by EM011 in the ApcMin/+ mouse model

Abstract 939: Chemoprevention of familial adenomatous polyposis by EM011 in the ApcMin/+ mouse model

by Li, Shiwang, Ghaleb, Amy M., He, Jing, Bughani, Usha, Bialkowska, Agnieszka B., Yang, Vincent W., Joshi, Harish C.
Published in Cancer research (Chicago, Ill.) (15.04.2010)

Get full text

Journal Article

USE OF A CD6 BINDING PARTNER AND METHOD BASED THEREON

USE OF A CD6 BINDING PARTNER AND METHOD BASED THEREON

by BUGHANI USHA, NAIR PRADIP, MANIAN BALA S, BARVE ABHIJIT, MELARKODE RAMAKRISHNAN, MONTERO CASIMIRO JOSE ENRIQUE
Year of Publication 28.03.2016

Get full text

Patent

Use of itolizumab to reduce phosphorylation of CD6

Use of itolizumab to reduce phosphorylation of CD6

by Saha, Arindam, Melarkode, Ramakrishnan, Nair, Pradip, Sadashivarao, Ravindra Belavinakodige, Bughani, Usha
Year of Publication 08.08.2024

Get full text

Patent

USE OF ITOLIZUMAB TO REDUCE PHOSPHORYLATION OF CD6

USE OF ITOLIZUMAB TO REDUCE PHOSPHORYLATION OF CD6

by SAHA, Arindam, MELARKODE, Ramakrishnan, NAIR, Pradip, SADASHIVARAO, Ravindra Belavinakodige, BUGHANI, Usha
Year of Publication 28.03.2024

Get full text

Patent

Immunotherapy methods using anti-PD-L1 antibodies in combination with EGFR1 targeted-TGF-beta immunomodulatory fusion proteins

Immunotherapy methods using anti-PD-L1 antibodies in combination with EGFR1 targeted-TGF-beta immunomodulatory fusion proteins

by Nair, Reshmi, Srinivasa, Sreesha P, Govindappa, Nagaraj, Bughani, Usha
Year of Publication 13.07.2021

Get full text

Patent